JP4486761B2 - プロトン磁気共鳴スペクトル法を用いる結腸直腸腺腫および結腸直腸癌の診断方法 - Google Patents
プロトン磁気共鳴スペクトル法を用いる結腸直腸腺腫および結腸直腸癌の診断方法 Download PDFInfo
- Publication number
- JP4486761B2 JP4486761B2 JP2000620336A JP2000620336A JP4486761B2 JP 4486761 B2 JP4486761 B2 JP 4486761B2 JP 2000620336 A JP2000620336 A JP 2000620336A JP 2000620336 A JP2000620336 A JP 2000620336A JP 4486761 B2 JP4486761 B2 JP 4486761B2
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- magnetic resonance
- colorectal
- resonance spectroscopy
- colorectal cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000001333 Colorectal Neoplasms Diseases 0.000 title claims description 27
- 206010009944 Colon cancer Diseases 0.000 title claims description 25
- 238000004611 spectroscopical analysis Methods 0.000 title claims description 9
- 201000002758 colorectal adenoma Diseases 0.000 title description 5
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 32
- 201000011510 cancer Diseases 0.000 claims description 25
- 238000001228 spectrum Methods 0.000 claims description 14
- 201000010099 disease Diseases 0.000 claims description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 10
- 208000003200 Adenoma Diseases 0.000 claims description 7
- 238000005481 NMR spectroscopy Methods 0.000 claims description 7
- 239000006194 liquid suspension Substances 0.000 claims description 7
- 230000003595 spectral effect Effects 0.000 claims description 6
- 206010001233 Adenoma benign Diseases 0.000 claims description 5
- 230000002596 correlated effect Effects 0.000 claims 1
- 208000037062 Polyps Diseases 0.000 description 16
- 238000002052 colonoscopy Methods 0.000 description 11
- 230000035945 sensitivity Effects 0.000 description 11
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 10
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 10
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 10
- 238000001514 detection method Methods 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 210000001072 colon Anatomy 0.000 description 8
- 238000005100 correlation spectroscopy Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 208000004804 Adenomatous Polyps Diseases 0.000 description 7
- 241000792859 Enema Species 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 239000007920 enema Substances 0.000 description 7
- 229940095399 enema Drugs 0.000 description 7
- 229910052788 barium Inorganic materials 0.000 description 6
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 6
- 230000036541 health Effects 0.000 description 5
- 241000894007 species Species 0.000 description 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000439 tumor marker Substances 0.000 description 4
- 206010013554 Diverticulum Diseases 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 206010048832 Colon adenoma Diseases 0.000 description 2
- 206010061818 Disease progression Diseases 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 208000009956 adenocarcinoma Diseases 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 208000035269 cancer or benign tumor Diseases 0.000 description 2
- 230000000112 colonic effect Effects 0.000 description 2
- 230000005750 disease progression Effects 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000001613 neoplastic effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000022271 tubular adenoma Diseases 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 206010073306 Exposure to radiation Diseases 0.000 description 1
- 241000147041 Guaiacum officinale Species 0.000 description 1
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
- 206010052178 Lymphocytic lymphoma Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010036774 Proctitis Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001815 ascending colon Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000005460 biophysical method Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 201000010989 colorectal carcinoma Diseases 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000007727 cost benefit analysis Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009541 flexible sigmoidoscopy Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940091561 guaiac Drugs 0.000 description 1
- 208000017819 hyperplastic polyp Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 206010022694 intestinal perforation Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 238000009206 nuclear medicine Methods 0.000 description 1
- -1 polytetrafluoroethylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012765 tissue examination method Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- High Energy & Nuclear Physics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13503999P | 1999-05-20 | 1999-05-20 | |
| US60/135,039 | 1999-05-20 | ||
| PCT/US2000/013329 WO2000071997A1 (en) | 1999-05-20 | 2000-05-16 | Method of diagnosing colorectal adenomas and cancer using proton magnetic resonance spectroscopy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003500644A JP2003500644A (ja) | 2003-01-07 |
| JP2003500644A5 JP2003500644A5 (enExample) | 2006-01-05 |
| JP4486761B2 true JP4486761B2 (ja) | 2010-06-23 |
Family
ID=22466222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000620336A Expired - Fee Related JP4486761B2 (ja) | 1999-05-20 | 2000-05-16 | プロトン磁気共鳴スペクトル法を用いる結腸直腸腺腫および結腸直腸癌の診断方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1188045A4 (enExample) |
| JP (1) | JP4486761B2 (enExample) |
| AU (1) | AU772906B2 (enExample) |
| CA (1) | CA2373598C (enExample) |
| WO (1) | WO2000071997A1 (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5741650A (en) * | 1996-01-30 | 1998-04-21 | Exact Laboratories, Inc. | Methods for detecting colon cancer from stool samples |
-
2000
- 2000-05-16 CA CA002373598A patent/CA2373598C/en not_active Expired - Fee Related
- 2000-05-16 AU AU48511/00A patent/AU772906B2/en not_active Ceased
- 2000-05-16 WO PCT/US2000/013329 patent/WO2000071997A1/en not_active Ceased
- 2000-05-16 EP EP00930747A patent/EP1188045A4/en not_active Withdrawn
- 2000-05-16 JP JP2000620336A patent/JP4486761B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003500644A (ja) | 2003-01-07 |
| CA2373598C (en) | 2006-08-01 |
| EP1188045A4 (en) | 2006-03-01 |
| EP1188045A1 (en) | 2002-03-20 |
| WO2000071997A1 (en) | 2000-11-30 |
| CA2373598A1 (en) | 2000-11-30 |
| AU772906B2 (en) | 2004-05-13 |
| AU4851100A (en) | 2000-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tsuzuki et al. | Usefulness and problems of endoscopic ultrasonography in prediction of the depth of tumor invasion in early gastric cancer | |
| KR20090122638A (ko) | 비행시간이차이온질량분광법을 이용한 질병의 진단 방법,질병 지표의 스크린 방법, 및 질병 지표 | |
| US20060269972A1 (en) | Method of diagnosing colorectal adenomas and cancer using infrared spectroscopy | |
| US6821784B1 (en) | Method of diagnosing colorectal adenomas and cancer using proton magnetic resonance spectroscopy | |
| Małkowski et al. | 18F‐FLT PET/CT in Patients with Gastric Carcinoma | |
| JP4486761B2 (ja) | プロトン磁気共鳴スペクトル法を用いる結腸直腸腺腫および結腸直腸癌の診断方法 | |
| EP1588181B1 (en) | Method of diagnosing colorectal adenomas and cancer using proton magnetic resonance spectroscopy | |
| US20030148260A1 (en) | Method of diagnosing colorectal adenomas and cancer using proton maggnetic resonance spectroscopy | |
| RU2464574C1 (ru) | Способ диагностики рака предстательной железы | |
| AU2001283735B2 (en) | Method of diagnosing colorectal adenomas and cancer using proton magnetic resonance spectroscopy | |
| Mukherjee et al. | Types of cancer diagnostics, the current achievements, and challenges | |
| AU2001283735A1 (en) | Method of diagnosing colorectal adenomas and cancer using proton magnetic resonance spectroscopy | |
| Dekel et al. | Method of infrared thermography for earlier diagnostics of gastric colorectal and cervical cancer | |
| US20100247438A1 (en) | In vitro method for diagnosing tumor diseases | |
| Williams et al. | An assessment of an immunochemical test for human haemoglobin in the detection of colonic polyps | |
| Didrikaitė et al. | Oral Microbiota: an Innovative Approach to Colorectal Cancer Diagnosis | |
| KR101106584B1 (ko) | 비행시간이차이온질량분광법을 이용한 질병 지표의 스크린 방법, 질병 지표, 및 질병 진단 장치 | |
| Jiang et al. | Colorectal cancer with indeterminate pulmonary nodules. | |
| Tomizawa et al. | Diffusion-weighted whole‑body imaging with background body signal suppression/T2 image fusion for the diagnosis of colorectal polyp and cancer | |
| Pingkan Siregar et al. | Tumor apparent diffusion coefficient value and ratio in magnetic resonance imaging on cervical cancer | |
| Bhutani et al. | Is endoscopic ultrasound “sound” for pancreatic cancer screening? | |
| Bezabeh et al. | 1H MRS of human stool: A simple non-invasive approach for diagnosing colorectal cancer | |
| Ahmed et al. | Role of diffusion-weighted magnetic resonance imaging in evaluation of chronic kidney disease | |
| Brito et al. | EX VIVO FLUORESCENCE IMAGING OF UROTHELIAL CARCINOMA IN HUMAN BLADDERS TARGETED BY ICG-PHLIP: MP49-20 | |
| US20190361024A1 (en) | Enhanced colorectal cancer screening |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050805 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070516 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091008 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100106 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100114 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100208 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100311 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100329 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130402 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130402 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140402 Year of fee payment: 4 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |